JP2011219478A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011219478A5 JP2011219478A5 JP2011104172A JP2011104172A JP2011219478A5 JP 2011219478 A5 JP2011219478 A5 JP 2011219478A5 JP 2011104172 A JP2011104172 A JP 2011104172A JP 2011104172 A JP2011104172 A JP 2011104172A JP 2011219478 A5 JP2011219478 A5 JP 2011219478A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- cdr1
- cdr3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011104172A JP2011219478A (ja) | 2009-03-19 | 2011-05-09 | 関節リウマチ治療剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009067358 | 2009-03-19 | ||
| JP2009067358 | 2009-03-19 | ||
| JP2011104172A JP2011219478A (ja) | 2009-03-19 | 2011-05-09 | 関節リウマチ治療剤 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010511837A Division JP4809930B2 (ja) | 2009-03-19 | 2010-03-19 | 関節リウマチ治療剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011219478A JP2011219478A (ja) | 2011-11-04 |
| JP2011219478A5 true JP2011219478A5 (enExample) | 2013-05-02 |
Family
ID=42739764
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010511837A Active JP4809930B2 (ja) | 2009-03-19 | 2010-03-19 | 関節リウマチ治療剤 |
| JP2011104172A Pending JP2011219478A (ja) | 2009-03-19 | 2011-05-09 | 関節リウマチ治療剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010511837A Active JP4809930B2 (ja) | 2009-03-19 | 2010-03-19 | 関節リウマチ治療剤 |
Country Status (5)
| Country | Link |
|---|---|
| JP (2) | JP4809930B2 (enExample) |
| KR (1) | KR101314880B1 (enExample) |
| RU (1) | RU2524152C2 (enExample) |
| TW (1) | TWI457134B (enExample) |
| WO (1) | WO2010107108A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4793360A2 (en) | 2006-03-31 | 2026-08-19 | Chugai Seiyaku Kabushiki Kaisha | Methods for controlling blood pharmacokinetics of antibodies |
| MX2009007830A (es) | 2007-01-23 | 2009-10-07 | Univ Shinshu | Inhibidor de rechazo cronico. |
| TW201503898A (zh) | 2008-06-05 | 2015-02-01 | Chugai Pharmaceutical Co Ltd | 神經浸潤抑制劑 |
| TWI440469B (zh) | 2008-09-26 | 2014-06-11 | Chugai Pharmaceutical Co Ltd | Improved antibody molecules |
| RS63800B1 (sr) | 2010-05-28 | 2022-12-30 | Chugai Pharmaceutical Co Ltd | Poboljšanje antitumorskog odgovora t ćelije |
| TWI654203B (zh) | 2010-11-30 | 2019-03-21 | Chugai Seiyaku Kabushiki Kaisha | 具有鈣依存性的抗原結合能力之抗體 |
| EP3009518B1 (en) | 2013-06-11 | 2020-08-12 | National Center of Neurology and Psychiatry | Method for predicting post-therapy prognosis of relapsing-remitting multiple sclerosis (rrms) patient, and method for determining applicability of novel therapy |
| TWI759261B (zh) | 2015-02-27 | 2022-04-01 | 日商中外製藥股份有限公司 | Ｉｌ－６受體抗體用於製備醫藥組成物的用途 |
| JP6875683B2 (ja) | 2015-05-19 | 2021-05-26 | 国立研究開発法人国立精神・神経医療研究センター | 多発性硬化症（ｍｓ）患者の新規治療適用判断方法 |
| EP3620531A4 (en) | 2017-05-02 | 2021-03-17 | National Center of Neurology and Psychiatry | METHOD OF PREDICTION AND EVALUATION OF THERAPEUTIC EFFECT IN DISEASES RELATING TO IL-6 AND NEUTROPHILS |
| WO2019078344A1 (ja) | 2017-10-20 | 2019-04-25 | 学校法人兵庫医科大学 | 抗ｉｌ－６受容体抗体を含有する術後の癒着を抑制するための医薬組成物 |
| TWI822728B (zh) | 2018-01-31 | 2023-11-21 | 加藤元一 | 含有il-6抑制劑的哮喘治療劑 |
| JPWO2020202839A1 (enExample) | 2019-03-29 | 2020-10-08 | ||
| AU2020259884A1 (en) | 2019-04-17 | 2021-10-07 | Chugai Seiyaku Kabushiki Kaisha | Therapeutic agent for urological cancer which is characterized by being administered with il-6 inhibitor and ccr2 inhibitor in combination |
| US12558423B2 (en) | 2020-05-29 | 2026-02-24 | Chugai Seiyaku Kabushiki Kaisha | Antibody-containing formulation |
| CN117320749A (zh) | 2021-03-12 | 2023-12-29 | 中外制药株式会社 | 用于治疗或预防重症肌无力的药物组合物 |
| WO2025198912A1 (en) | 2024-03-21 | 2025-09-25 | Hoffmann-La Roche Inc. | Methods of treating myasthenia gravis |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL182089B1 (en) * | 1994-10-21 | 2001-11-30 | Chugai Pharmaceutical Co Ltd | Pharmaceutic compositions for treating diseases caused by production of il-6 |
| RU2481356C2 (ru) * | 2004-12-28 | 2013-05-10 | Иннейт Фарма | Моноклональные антитела против nkg2a |
| JP2010500876A (ja) * | 2006-08-18 | 2010-01-14 | アブリンクス エン．ヴェー． | Ｉｌ−６媒介性シグナル伝達に関連する疾患及び障害の治療のための、ｉｌ−６ｒに指向性を有するアミノ酸配列及びこれを含むポリペプチド |
| WO2009010539A2 (en) * | 2007-07-19 | 2009-01-22 | Ablynx. N.V. | Receptor for interleukin-6 (il-6) from macaca fascicularis |
| RU2505603C2 (ru) * | 2007-09-26 | 2014-01-27 | Чугаи Сейяку Кабусики Кайся | Антитело против рецептора il-6 |
| ES2687808T3 (es) * | 2007-09-26 | 2018-10-29 | Chugai Seiyaku Kabushiki Kaisha | Región constante de anticuerpo modificado |
| TW201920257A (zh) * | 2008-04-11 | 2019-06-01 | 日商中外製藥股份有限公司 | 重複結合複數個抗原的抗原結合分子 |
| TWI440469B (zh) * | 2008-09-26 | 2014-06-11 | Chugai Pharmaceutical Co Ltd | Improved antibody molecules |
-
2010
- 2010-03-19 TW TW099108133A patent/TWI457134B/zh active
- 2010-03-19 RU RU2011142183/10A patent/RU2524152C2/ru active
- 2010-03-19 JP JP2010511837A patent/JP4809930B2/ja active Active
- 2010-03-19 WO PCT/JP2010/054763 patent/WO2010107108A1/ja not_active Ceased
- 2010-03-19 KR KR1020117024354A patent/KR101314880B1/ko active Active
-
2011
- 2011-05-09 JP JP2011104172A patent/JP2011219478A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012136541A5 (enExample) | ||
| JP2013517277A5 (enExample) | ||
| RU2011142183A (ru) | Средство для лечения ревматоидного артрита | |
| JP2017176174A5 (enExample) | ||
| JP2012507294A5 (enExample) | ||
| JP2014205674A5 (enExample) | ||
| JP2013539454A5 (enExample) | ||
| PH12014500089A1 (en) | Antibodies that bind to ox40 and their uses | |
| HRP20211343T1 (hr) | Protutijela protiv dkk-1 | |
| WO2012006596A3 (en) | Anti-human respiratory syncytial virus (rsv) antibodies and methods of use | |
| CA2813849C (en) | Secukinumab for use in the treatment of ankylosing spondylitis | |
| HRP20192295T1 (hr) | Optimizirana monoklonska protutijela protiv inhibitora faktora tkivnog puta (tfpi) | |
| JP2015522252A5 (enExample) | ||
| JP2018510132A5 (enExample) | ||
| HRP20161740T1 (hr) | Ljudske molekule za vezanje koje su sposobne neutralizirati viruse influence a filogenetske skupine 1 i filogenetske skupine 2, te viruse influence b | |
| NZ709390A (en) | Folate receptor 1 antibodies and immunoconjugates and uses thereof | |
| JP2015514110A5 (enExample) | ||
| JP2018536393A5 (enExample) | ||
| JP2014074046A5 (enExample) | ||
| JP2011528902A5 (enExample) | ||
| JP2012010714A5 (enExample) | ||
| JP2014526898A5 (enExample) | ||
| JP2015530399A5 (enExample) | ||
| JP2012126742A5 (enExample) | ||
| JP2007051159A5 (enExample) |